Value of oral glucose tolerance test in the acute phase of myocardial infarction

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Bronisz, Agata ^a   Kozinski, Marek ^a   Magielski, Przemyslaw ^a   Fabiszak, Tomasz ^a   Gierach, Joanna ^a   Swiatkiewicz, Iwona ^a   Sukiennik, Adam ^a   Kubica, Aldona ^a   Bronisz, Marek ^b   Grabczewska, Zofia ^a   Sinkiewicz, Anna ^a   Junik, Roman ^a   Kubica, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b PS ZOZ Regional Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ACUTE HEART INFARCTION; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HOSPITAL DISCHARGE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; BLOOD; CHI SQUARE DISTRIBUTION; DISCRIMINANT ANALYSIS; DISORDERS OF CARBOHYDRATE METABOLISM; GLUCOSE TOLERANCE TEST; HEART INFARCTION; HOSPITAL ADMISSION; METABOLISM; MIDDLE AGED; POLAND; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DISCRIMINANT ANALYSIS; FEMALE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PATIENT DISCHARGE; POLAND; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS;

EID: 79952474969     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-21     Document Type: Article

References (20)

1. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28(1):88-136.
2. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, . ESC Committee for Practice Guidelines (CPG) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008, 29(23):2909-2945. 10.1093/eurheartj/ehn416, 19004841, ESC Committee for Practice Guidelines (CPG).
3. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002, 359(9324):2140-2144. 10.1016/S0140-6736(02)09089-X, 12090978.
4. Wallander M, Malmberg K, Norhammar A, Rydén L, Tenerz A. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care 2008, 31(1):36-38. 10.2337/dc07-1552, 17909086.
5. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO. Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol 2009, 8:6. 10.1186/1475-2840-8-6, 2646717, 19183453.
6. Myocardial infarction redefined - A consensus of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000, 21(18):1502-1513. 10.1053/euhj.2000.2305, 10973764.
7. Gasior M, Pres D, Stasik-Pres G, Lech P, Gierlotka M, Hawranek M, Wilczek K, Szyguła-Jurkiewicz B, Lekston A, Kalarus Z, Strojek K, Gumprecht J, Poloński L. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J 2008, 15(5):422-430.
8. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008, 117(8):1018-1027. 10.1161/CIRCULATIONAHA.107.740498, 18268145.
9. Kralev S, Krause B, Papavassiliu T, Lang S, Haghi D, Kälsch T, Dempfle CE, Borggrefe M, Süselbeck T. Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors. Cardiol J 2009, 16(3):234-240.
10. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM. Diabetes and mortality following acute coronary syndrome. JAMA 2007, 298(7):765-775. 10.1001/jama.298.7.765, 17699010.
11. Timmer JR, Ottervanger JP, Thomas K, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F, . Zwolle Myocardial Infarction Study Group Long-term, cause-specific mortality after myocardial infarction in diabetes. Eur Heart J 2004, 25(11):926-931. 10.1016/j.ehj.2004.04.001, 15172464, Zwolle Myocardial Infarction Study Group.
12. Zare{ogonek}ba W. Hyperglycemia as a risk factor in postinfarction patients. Cardiol J 2008, 15(5):399-401.
13. Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, Standl E, Soler-Soler J, Ohrvik J, . Euro Heart Survey Investigators The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. Eur Heart J 2004, 25(21):1880-1890. 10.1016/j.ehj.2004.07.027, 15522466, Euro Heart Survey Investigators.
14. Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J 2006, 27(21):2573-2579. 10.1093/eurheartj/ehl207, 16984927.
15. Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Rydén L, Malmberg K. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003, 26(10):2770-2776. 10.2337/diacare.26.10.2770, 14514578.
16. Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, Valagussa F, Marchioli R. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet 2007, 370(9588):667-675. 10.1016/S0140-6736(07)61343-9, 17720018.
17. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, Nakama Y, Kijima Y, Kagawa E. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?. Eur Heart J 2006, 27(20):2413-2419. 10.1093/eurheartj/ehl271, 17000629.
18. Tenerz T, Lönneberg I, Berne C, Nilsson G, Leppert J. Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes?. Eur Heart J 2001, 22(13):1102-1110. 10.1053/euhj.2000.2445, 11428850.
19. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: A report of the World Health Organization and International Diabetes Federation 2006, Geneva: WHO Press.
20. Barrett-Connor E. The oral glucose tolerance test, revisited. Eur Heart J 2002, 23(16):1229-1231. 10.1053/euhj.2002.3243, 12175655.